Newton Charles W.

Insider profile

Performance

Overall performance
1.5

Performance over holding periods
4.2
30 days 90 days 120 days
Average return -22% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
3 33% Buy
34 71% Buy
47 69% Buy
Performance for realised trades
4.4
Average return -6%
Success rate 73%
Average holding period 220
Transactions 28
Newton Charles W.'s trades of Keros Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-06-15 2026-06-11 PlS Planned sale
9,658 +8.4%
175.64
US$3,719,933
9,658 +8.4% 175.64 US$3,719,933
2026-06-11 2026-06-11 PrS Proposed sale
65,573
286.74
US$3,076,150
65,573 286.74 US$3,076,150
2025-08-22 2025-08-21 S Sale
38,621 -31.0%
376.98
US$1,509,913
38,621 -31.0% 376.98 US$1,509,913
2025-08-13 2025-08-12 S Sale
136 -1.5%
10.34
US$1,406
136 -1.5% 10.34 US$1,406
2025-08-13 2025-08-11 PlS Planned sale
131 -1.5%
10.53
US$1,379
131 -1.5% 10.53 US$1,379
2025-03-18 2025-03-17 B Purchase
200,000 +inf%
0.56
US$111,620
200,000 +inf% 0.56 US$111,620